• Je něco špatně v tomto záznamu ?

Large Animal Models of Huntington's Disease: What We Have Learned and Where We Need to Go Next

D. Howland, Z. Ellederova, N. Aronin, D. Fernau, J. Gallagher, A. Taylor, J. Hennebold, AR. Weiss, H. Gray-Edwards, J. McBride

. 2020 ; 9 (3) : 201-216. [pub] -

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc21026780

Grantová podpora
P51 OD011092 NIH HHS - United States
P51 RR000163 NCRR NIH HHS - United States
R01 NS099136 NINDS NIH HHS - United States

Genetically modified rodent models of Huntington's disease (HD) have been especially valuable to our understanding of HD pathology and the mechanisms by which the mutant HTT gene alters physiology. However, due to inherent differences in genetics, neuroanatomy, neurocircuitry and neurophysiology, animal models do not always faithfully or fully recapitulate human disease features or adequately predict a clinical response to treatment. Therefore, conducting translational studies of candidate HD therapeutics only in a single species (i.e. mouse disease models) may not be sufficient. Large animal models of HD have been shown to be valuable to the HD research community and the expectation is that the need for translational studies that span rodent and large animal models will grow. Here, we review the large animal models of HD that have been created to date, with specific commentary on differences between the models, the strengths and disadvantages of each, and how we can advance useful models to study disease pathophysiology, biomarker development and evaluation of promising therapeutics.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21026780
003      
CZ-PrNML
005      
20211026132626.0
007      
ta
008      
211013s2020 ne f 000 0|eng||
009      
AR
024    7_
$a 10.3233/JHD-200425 $2 doi
035    __
$a (PubMed)32925082
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Howland, David $u CHDI Management/CHDI Foundation, Princeton, NJ, USA
245    10
$a Large Animal Models of Huntington's Disease: What We Have Learned and Where We Need to Go Next / $c D. Howland, Z. Ellederova, N. Aronin, D. Fernau, J. Gallagher, A. Taylor, J. Hennebold, AR. Weiss, H. Gray-Edwards, J. McBride
520    9_
$a Genetically modified rodent models of Huntington's disease (HD) have been especially valuable to our understanding of HD pathology and the mechanisms by which the mutant HTT gene alters physiology. However, due to inherent differences in genetics, neuroanatomy, neurocircuitry and neurophysiology, animal models do not always faithfully or fully recapitulate human disease features or adequately predict a clinical response to treatment. Therefore, conducting translational studies of candidate HD therapeutics only in a single species (i.e. mouse disease models) may not be sufficient. Large animal models of HD have been shown to be valuable to the HD research community and the expectation is that the need for translational studies that span rodent and large animal models will grow. Here, we review the large animal models of HD that have been created to date, with specific commentary on differences between the models, the strengths and disadvantages of each, and how we can advance useful models to study disease pathophysiology, biomarker development and evaluation of promising therapeutics.
650    _2
$a zvířata $7 D000818
650    12
$a geneticky modifikovaná zvířata $7 D030801
650    12
$a modely nemocí na zvířatech $7 D004195
650    12
$a Huntingtonova nemoc $x genetika $x patologie $x patofyziologie $x terapie $7 D006816
650    _2
$a primáti $7 D011323
650    _2
$a ovce $7 D012756
650    _2
$a prasata $7 D013552
650    _2
$a miniaturní prasata $7 D013556
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Ellederova, Zdenka $u Institute of Animal Physiology and Genetics, Libechov, Czech Republic
700    1_
$a Aronin, Neil $u Horae Gene Therapy Center and RNA Therapeutics Institute at The University of Massachusetts Medical School, Worcester, MA, USA
700    1_
$a Fernau, Deborah $u Horae Gene Therapy Center and RNA Therapeutics Institute at The University of Massachusetts Medical School, Worcester, MA, USA
700    1_
$a Gallagher, Jill $u Horae Gene Therapy Center and RNA Therapeutics Institute at The University of Massachusetts Medical School, Worcester, MA, USA
700    1_
$a Taylor, Amanda $u Diplomate, MedVet, American College of Veterinary Internal Medicine - Neurology, Columbus, OH, USA
700    1_
$a Hennebold, Jon $u Oregon National Primate Research Center at The Oregon Health and Science University, Portland, OR, USA
700    1_
$a Weiss, Alison R $u Oregon National Primate Research Center at The Oregon Health and Science University, Portland, OR, USA
700    1_
$a Gray-Edwards, Heather $u Horae Gene Therapy Center and RNA Therapeutics Institute at The University of Massachusetts Medical School, Worcester, MA, USA
700    1_
$a McBride, Jodi $u Oregon National Primate Research Center at The Oregon Health and Science University, Portland, OR, USA
773    0_
$w MED00184837 $t Journal of Huntington's disease $x 1879-6400 $g Roč. 9, č. 3 (2020), s. 201-216
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32925082 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026132632 $b ABA008
999    __
$a ok $b bmc $g 1715508 $s 1147287
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 9 $c 3 $d 201-216 $e - $i 1879-6400 $m Journal of Huntington's disease $n J Huntingtons Dis $x MED00184837
GRA    __
$a P51 OD011092 $p NIH HHS $2 United States
GRA    __
$a P51 RR000163 $p NCRR NIH HHS $2 United States
GRA    __
$a R01 NS099136 $p NINDS NIH HHS $2 United States
LZP    __
$a Pubmed-20211013

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace